Levofacetoperane or levophacetoperane

This classification denotes a cns stimulant with the molecular formula C15H21NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3SZ9ZII529, chemically known as 2-piperidinemethanol, alpha-phenyl-, acetate (ester), (r*,r*)-(-)- but more generally known as levofacetoperane, which bears US NIH Compound Identifier 65715. European Medicines Agency schedules Levofacetoperane in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08469MIG. The term LEVOFACETOPERANE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 33, No. 10 1979, List 19). LEVOFACETOPERANE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Levofacetoperane or levophacetoperane bears US NLM identifiers UMLS ID C0064875 and NCI Concept Code C81053. SMILES: CC(=O)OC(C1CCCCN1)C2=CC=CC=C2.